Saroja Pharma Industries India Ltd. - Research Center
Results
|
Annual
|
Statement
|
|
More
|
|
Annual results in brief
(Rs crore)
|
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 20 |
Sales |
40.67 |
50.19 |
55.63 |
17.08 |
Operating profit |
2.55 |
2.72 |
2.10 |
0.37 |
Interest |
1.45 |
1.32 |
0.80 |
0.16 |
Gross profit |
1.30 |
1.56 |
1.62 |
0.22 |
EPS (Rs) |
2.18 |
3.61 |
50.49 |
160.93 |
Annual
results in details
|
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 20 |
Other income |
0.19 |
0.16 |
0.32 |
0.01 |
Stock adjustment |
3.47 |
-3.40 |
0.19 |
-0.06 |
Raw material |
32.17 |
47.71 |
48.32 |
- |
Power and fuel |
- |
- |
- |
- |
Employee expenses |
1.46 |
1.37 |
1.14 |
0.61 |
Excise |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
Other expenses |
1.01 |
1.79 |
3.88 |
16.16 |
Provisions made |
- |
- |
- |
- |
Depreciation |
0.09 |
0.07 |
0.05 |
- |
Taxation |
0.33 |
0.43 |
0.44 |
0.05 |
Net profit / loss |
0.88 |
1.06 |
1.14 |
0.16 |
Extra ordinary item |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
Equity capital |
4.02 |
2.94 |
0.23 |
0.01 |
Equity dividend rate |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
OPM (%) |
6.28 |
5.42 |
3.78 |
2.18 |
GPM (%) |
3.19 |
3.09 |
2.90 |
1.29 |
NPM (%) |
2.15 |
2.11 |
2.04 |
0.94 |